Experimental Cancer Vaccine Shows Promise for Kidney Cancer Patients

A new study on an experimental cancer vaccine shows promising results for kidney cancer patients, with all participants remaining cancer-free after receiving personalized vaccines tailored to their tumor types. The vaccine boosted the immune response and T-cell activity, leading to long-lasting effects.

mRNA Cancer Vaccine Shows Promise in Treating Aggressive Brain Tumours

A new mRNA cancer vaccine has shown promising results in reprogramming the immune system to attack tumours within 48 hours in a human clinical trial. The vaccine is personalized using the patient's own DNA and has the potential to improve treatment for aggressive brain tumours.